These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20102920)

  • 1. Mutation-specific risk in two genetic forms of type 3 long QT syndrome.
    Liu JF; Moss AJ; Jons C; Benhorin J; Schwartz PJ; Spazzolini C; Crotti L; Ackerman MJ; McNitt S; Robinson JL; Qi M; Goldenberg I; Zareba W
    Am J Cardiol; 2010 Jan; 105(2):210-3. PubMed ID: 20102920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
    Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
    Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
    Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.
    Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL
    Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.
    Wilde AA; Moss AJ; Kaufman ES; Shimizu W; Peterson DR; Benhorin J; Lopes C; Towbin JA; Spazzolini C; Crotti L; Zareba W; Goldenberg I; Kanters JK; Robinson JL; Qi M; Hofman N; Tester DJ; Bezzina CR; Alders M; Aiba T; Kamakura S; Miyamoto Y; Andrews ML; McNitt S; Polonsky B; Schwartz PJ; Ackerman MJ
    Circulation; 2016 Sep; 134(12):872-82. PubMed ID: 27566755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the SCN5A gene: evidence for a link between long QT syndrome and sudden death?
    Kiehne N; Kauferstein S
    Forensic Sci Int Genet; 2007 Jun; 1(2):170-4. PubMed ID: 19083750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
    Migdalovich D; Moss AJ; Lopes CM; Costa J; Ouellet G; Barsheshet A; McNitt S; Polonsky S; Robinson JL; Zareba W; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Goldenberg I
    Heart Rhythm; 2011 Oct; 8(10):1537-43. PubMed ID: 21440677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.
    Zareba W; Moss AJ; Schwartz PJ; Vincent GM; Robinson JL; Priori SG; Benhorin J; Locati EH; Towbin JA; Keating MT; Lehmann MH; Hall WJ
    N Engl J Med; 1998 Oct; 339(14):960-5. PubMed ID: 9753711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
    Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S
    Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome.
    Mathias A; Moss AJ; Lopes CM; Barsheshet A; McNitt S; Zareba W; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Qi M; Shimizu W; Towbin JA; Michael Vincent G; Wilde AA; Zhang L; Goldenberg I
    Heart Rhythm; 2013 May; 10(5):720-5. PubMed ID: 23369741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.
    Platonov PG; McNitt S; Polonsky B; Rosero SZ; Kutyifa V; Huang A; Moss AJ; Zareba W
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e005918. PubMed ID: 30012873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
    Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome.
    Liu JF; Jons C; Moss AJ; McNitt S; Peterson DR; Qi M; Zareba W; Robinson JL; Barsheshet A; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin J; Vincent M; Zhang L; Goldenberg I;
    J Am Coll Cardiol; 2011 Feb; 57(8):941-50. PubMed ID: 21329841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA-based diagnostics of long QT syndrome].
    Berge KE; Haugaa KH; Anfinsen OG; Früh A; Hallerud M; Jonsrud C; Øyen N; Gjesdal K; Amlie JP; Leren TP
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2783-6. PubMed ID: 16244680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of ion channel gene variants in patients with long QT syndrome.
    Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
    Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.